Log in
NYSEAMERICAN:INFU

InfuSystem Stock Forecast, Price & News

$13.82
+0.71 (+5.42 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$13.19
Now: $13.82
$14.26
50-Day Range N/A
52-Week Range
$5.19
Now: $13.82
$15.19
Volume126,954 shs
Average Volume105,087 shs
Market Capitalization$279.14 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees237
Market Cap$279.14 million
Next Earnings Date11/11/2020 (Estimated)
OptionableNot Optionable
$13.82
+0.71 (+5.42 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of InfuSystem?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InfuSystem in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for InfuSystem
.

When is InfuSystem's next earnings date?

InfuSystem is scheduled to release its next quarterly earnings announcement on Wednesday, November 11th 2020.
View our earnings forecast for InfuSystem
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) announced its quarterly earnings data on Thursday, August, 13th. The medical instruments supplier reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.17. The medical instruments supplier had revenue of $26 million for the quarter.
View InfuSystem's earnings history
.

What guidance has InfuSystem issued on next quarter's earnings?

InfuSystem issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, August, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $94-97 million, compared to the consensus revenue estimate of $88 million.

What price target have analysts set for INFU?

2 brokerages have issued 1-year price targets for InfuSystem's stock. Their forecasts range from $17.00 to $28.00. On average, they anticipate InfuSystem's share price to reach $22.50 in the next year. This suggests a possible upside of 62.8% from the stock's current price.
View analysts' price targets for InfuSystem
.

Are investors shorting InfuSystem?

InfuSystem saw a decline in short interest in August. As of August 31st, there was short interest totaling 320,300 shares, a decline of 14.9% from the August 15th total of 376,600 shares. Based on an average trading volume of 139,300 shares, the short-interest ratio is currently 2.3 days. Approximately 1.8% of the company's stock are short sold.
View InfuSystem's Short Interest
.

Who are some of InfuSystem's key competitors?

What other stocks do shareholders of InfuSystem own?

Who are InfuSystem's key executives?

InfuSystem's management team includes the following people:
  • Mr. Richard A. DiIorio, Pres, CEO & Director (Age 44)
  • Mr. Gregory Schulte, Exec. VP & CFO (Age 52)
  • Mr. Thomas Mark Ruiz, Sr. VP of Sales & Marketing
  • Mr. John Haggerty, Sr. VP of Biomedical Services & Logistics
  • Ms. Jean Pfeiffer, Sr. VP of Strategic Initiatives

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include FMR LLC (2.33%), FMR LLC (2.31%), Teton Advisors Inc. (2.09%), White Pine Capital LLC (1.03%), EAM Investors LLC (0.91%) and Bridgeway Capital Management Inc. (0.77%). Company insiders that own InfuSystem stock include Awm Investment Company, Inc, Barry G Steele, Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Meridian Ohc Partners, Lp, Paul Andrew Gendron, Richard Dilorio, Scott Shuda and Thomas Mark Ruiz.
View institutional ownership trends for InfuSystem
.

Which institutional investors are selling InfuSystem stock?

INFU stock was sold by a variety of institutional investors in the last quarter, including Bridgeway Capital Management Inc., Teton Advisors Inc., Gabelli Funds LLC, and Bank of America Corp DE. Company insiders that have sold InfuSystem company stock in the last year include Gregg Owen Lehman, Meridian Ohc Partners, Lp, Richard Dilorio, Scott Shuda, and Thomas Mark Ruiz.
View insider buying and selling activity for InfuSystem
.

Which institutional investors are buying InfuSystem stock?

INFU stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, FMR LLC, EAM Investors LLC, UBS Group AG, Nuveen Asset Management LLC, Mackay Shields LLC, Charles Schwab Investment Management Inc., and Bank of New York Mellon Corp. Company insiders that have bought InfuSystem stock in the last two years include Awm Investment Company, Inc, Barry G Steele, Carrie Lachance, Christopher R Sansone, Jeannine Sheehan, Paul Andrew Gendron, Richard Dilorio, and Scott Shuda.
View insider buying and selling activity for InfuSystem
.

How do I buy shares of InfuSystem?

Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $13.82.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $279.14 million. InfuSystem employs 237 workers across the globe.

What is InfuSystem's official website?

The official website for InfuSystem is ir.infusystem.com.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.